Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis?
Robert Zivadinov, Istvan Pirko
Neurology
Research output
:
Contribution to journal
›
Editorial
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Gray Matter
100%
Multiple Sclerosis
87%
Pathology
62%
Neurology
13%
Longitudinal Studies
10%
Cognitive Dysfunction
10%
Immunohistochemistry
8%
Cross-Sectional Studies
8%
Staining and Labeling
7%
Antigens
7%
Biopsy
7%
Inflammation
7%
Therapeutics
2%